NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: Multiple Sclerosis Center of Catalonia
Conditions: Multiple Sclerosis
Interventions: Telerehab
Countries: Spain
The goal of this clinical trial is to assessing safety and the occurrence of adverse effects during tele-rehabilitation (TRHB) in people with multiple sclerosis with an EDSS score of 6.5 or lower. The main questions it aims to answer are: * Intervention using TRHB is considered safe and without adverse effects. * Intervention using TRHB has a high degree of self-adherence, an impact on physical activity levels and self-efficacy in exercise, and a positive effect on quality of life, mood, and perception of fatigue. Researchers will compare the tele-rehabilitation with rehabilitation based solely on physical activity recommendations. Participants will complete three weekly online rehabilitation sessions and must attend three follow-up visits.
Sex: ALL
Age: 18 Years to —
Healthy volunteers: No
Study type: INTERVENTIONAL
Inclusion Criteria: * Patients diagnosed with multiple sclerosis confirmed using the 2017 McDonald criteria. * Patients who have the technological means to conduct online sessions and the autonomy to do so. * Patients with cognitive capacity that allows them to sign the informed consent form. * Patients with an internet connection and a device compatible with the Rehub tele-rehabilitation platform (desktop computer, laptop, or tablet). * EDSS level less than or equal to 6.5. Exclusion Criteria: * Participants who are currently undergoing RHB at a center. * Participants who have undergone RHB during the two months prior to the start of the program. * Patients with physical or mental comorbidities that may limit their participation in the rehabilitation program.
- Barcelona, Spain